MAK Capital and related entities reported beneficial ownership of 26,172,626 shares of Standard BioTools Inc. common stock, representing 6.7% of the class. The filing states the share count is as of 05/15/2026 and references 390,368,119 shares outstanding as of May 4, 2026.
The Schedule 13G/A lists shared voting and dispositive power over the 26,172,626 shares and identifies MAK Capital Fund LP, MAK Capital One L.L.C., and Michael A. Kaufman as reporting persons. Signatures are dated 05/15/2026.
Positive
None.
Negative
None.
Insights
MAK Capital disclosed a passive 6.7% stake in Standard BioTools.
The filing lists 26,172,626 shares beneficially owned as of 05/15/2026 and reports shared voting and dispositive power. The ownership percentage is calculated against 390,368,119 shares outstanding as of May 4, 2026.
Cash‑flow treatment and sale intentions are not disclosed; subsequent SEC filings would show any transactional activity. Voting alignment and any board engagement should be tracked in future disclosures.
Key Figures
Shares beneficially owned:26,172,626 sharesPercent of class:6.7%Shares outstanding:390,368,119 shares+1 more
4 metrics
Shares beneficially owned26,172,626 sharesbeneficially owned as of <date>05/15/2026</date>
Percent of class6.7%calculated using 390,368,119 shares outstanding as of <date>May 4, 2026</date>
Shares outstanding390,368,119 sharesoutstanding as of <date>May 4, 2026</date>
Filing date / signature date05/15/2026signatures dated in Schedule 13G/A
Key Terms
Schedule 13G/A, beneficially owned, shared dispositive power
3 terms
Schedule 13G/Aregulatory
"This /A is being filed by: i. MAK Capital Fund LP"
A Schedule 13G/A is an amended public filing with the U.S. securities regulator that updates a previous Schedule 13G, disclosing when an individual or group holds a substantial (typically over 5%) stake in a company and is claiming a passive, non‑controlling intent. Investors monitor these updates because rising or falling holdings can signal changing confidence, potential future moves, or shifts in voting power — like watching a public ledger where large shareholders quietly adjust their positions.
beneficially ownedfinancial
"26,172,626 shares of Common Stock beneficially owned as of 05/15/2026"
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.
shared dispositive powerregulatory
"Shared Dispositive Power 26,172,626.00"
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
UNDER THE SECURITIES EXCHANGE ACT OF 1934
(Amendment No. 1)
STANDARD BIOTOOLS INC.
(Name of Issuer)
Common Stock, $0.001 par value per share
(Title of Class of Securities)
34385P108
(CUSIP Number)
03/31/2026
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)
schemaVersion:
SCHEDULE 13G
CUSIP Number(s):
34385P108
1
Names of Reporting Persons
MAK Capital Fund LP
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
BERMUDA
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
26,172,626.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
26,172,626.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
26,172,626.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
6.7 %
12
Type of Reporting Person (See Instructions)
PN
Comment for Type of Reporting Person: The calculation is based upon 26,172,626 shares of Common Stock beneficially owned as of 05/15/2026 and a total of 390,368,119 shares of Common Stock, $0.001 par value per share, outstanding as of May 4, 2026, as reported by the Issuer on its Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on May 6, 2026.
SCHEDULE 13G
CUSIP Number(s):
34385P108
1
Names of Reporting Persons
MAK Capital One L.L.C.
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
DELAWARE
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
26,172,626.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
26,172,626.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
26,172,626.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
6.7 %
12
Type of Reporting Person (See Instructions)
IA
Comment for Type of Reporting Person: The calculation is based upon 26,172,626 shares of Common Stock beneficially owned as of 05/15/2026 and a total of 390,368,119 shares of Common Stock, $0.001 par value per share, outstanding as of May 4, 2026, as reported by the Issuer on its Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on May 6, 2026.
SCHEDULE 13G
CUSIP Number(s):
34385P108
1
Names of Reporting Persons
Michael A. Kaufman
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
UNITED STATES
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
26,172,626.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
26,172,626.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
26,172,626.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
6.7 %
12
Type of Reporting Person (See Instructions)
IN
Comment for Type of Reporting Person: The calculation is based upon 26,172,626 shares of Common Stock beneficially owned as of 05/15/2026 and a total of 390,368,119 shares of Common Stock, $0.001 par value per share, outstanding as of May 4, 2026, as reported by the Issuer on its Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on May 6, 2026.
This Schedule 13G/A is being filed by:
i. MAK Capital Fund LP ("MAK Fund")
ii. MAK Capital One L.L.C. ("MAK Capital"); and
iii. Michael A. Kaufman ("Mr. Kaufman," and collectively with MAK Fund and MAK Capital, the "Reporting Persons")
(b)
Address or principal business office or, if none, residence:
The principal business address of (i) MAK Fund is c/o Wakefield Quin, Victoria Place, 31 Victoria Street, Bermuda; and (ii) MAK Capital and Mr. Kaufman is 590 Madison Avenue, 31st Floor, New York, NY 10022.
(c)
Citizenship:
MAK Capital Fund LP is a Bermuda limited partnership.
MAK Capital One L.L.C. is a Delaware limited liability company.
Mr. Kaufman is a United States citizen.
(d)
Title of class of securities:
Common Stock, $0.001 par value per share
(e)
CUSIP No.:
34385P108
Item 3.
If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)
Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)
Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)
Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)
Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)
An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)
An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)
A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)
A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)
A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)
A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J),
please specify the type of institution:
(k)
Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.
Ownership
(a)
Amount beneficially owned:
26,172,626
(b)
Percent of class:
6.7%
The calculation is based upon 26,172,626 shares of Common Stock beneficially owned as of 05/15/2026 and a total of 390,368,119 shares of Common Stock, $0.001 par value per share, outstanding as of May 4, 2026, as reported by the Issuer on its Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on May 6, 2026.
(c)
Number of shares as to which the person has:
(i) Sole power to vote or to direct the vote:
0
(ii) Shared power to vote or to direct the vote:
26,172,626
(iii) Sole power to dispose or to direct the disposition of:
0
(iv) Shared power to dispose or to direct the disposition of:
26,172,626
Item 5.
Ownership of 5 Percent or Less of a Class.
Not Applicable
Item 6.
Ownership of more than 5 Percent on Behalf of Another Person.
Not Applicable
Item 7.
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
Not Applicable
Item 8.
Identification and Classification of Members of the Group.
Not Applicable
Item 9.
Notice of Dissolution of Group.
Not Applicable
Item 10.
Certifications:
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
What stake does MAK Capital hold in Standard BioTools (LAB)?
MAK Capital reported ownership of 26,172,626 shares, equal to 6.7% of the class. The filing states the share count is as of 05/15/2026 and uses 390,368,119 shares outstanding as of May 4, 2026 for the percentage calculation.
Which entities and person filed the Schedule 13G/A for LAB?
The filing was made by MAK Capital Fund LP, MAK Capital One L.L.C., and Michael A. Kaufman. Addresses and citizenships are provided; signatures are dated 05/15/2026 and list Mr. Kaufman as Managing Member.
Does the filing show who controls voting or disposition of the shares?
The Schedule 13G/A reports shared voting and shared dispositive power over 26,172,626 shares. Sole voting and dispositive power are reported as zero, indicating the reporting persons state shared authority rather than exclusive control.
What outstanding share count was used to compute the 6.7% figure?
The percent is calculated using 390,368,119 shares outstanding as of May 4, 2026. That outstanding count is cited from the issuer's Form 10-Q filed on May 6, 2026 in the filing's explanatory comment.
